AU2680877A - Arylaminopyrimidine derivatives - Google Patents

Arylaminopyrimidine derivatives

Info

Publication number
AU2680877A
AU2680877A AU26808/77A AU2680877A AU2680877A AU 2680877 A AU2680877 A AU 2680877A AU 26808/77 A AU26808/77 A AU 26808/77A AU 2680877 A AU2680877 A AU 2680877A AU 2680877 A AU2680877 A AU 2680877A
Authority
AU
Australia
Prior art keywords
arylaminopyrimidine
derivatives
arylaminopyrimidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU26808/77A
Other languages
English (en)
Inventor
Claude Fauran
Guy Raynaud
Claude Gouret
Guy Bourgery
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7620775A external-priority patent/FR2357252A2/fr
Priority claimed from FR7718471A external-priority patent/FR2394543A2/fr
Application filed by Delalande SA filed Critical Delalande SA
Publication of AU2680877A publication Critical patent/AU2680877A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
AU26808/77A 1976-07-07 1977-07-06 Arylaminopyrimidine derivatives Pending AU2680877A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7620775A FR2357252A2 (fr) 1976-07-07 1976-07-07 Nouveaux derives arylaminopyrimidiniques, leur procede de preparation et leur application en therapeutique
FR7718471A FR2394543A2 (fr) 1977-06-16 1977-06-16 Nouveaux derives arylaminopyrimidiniques, leur procede de preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AU2680877A true AU2680877A (en) 1979-01-11

Family

ID=26219529

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26808/77A Pending AU2680877A (en) 1976-07-07 1977-07-06 Arylaminopyrimidine derivatives

Country Status (11)

Country Link
JP (1) JPS5312877A (xx)
AU (1) AU2680877A (xx)
CH (1) CH611283A5 (xx)
DE (1) DE2729360A1 (xx)
ES (1) ES460411A2 (xx)
GB (1) GB1548858A (xx)
IT (1) IT1114810B (xx)
LU (1) LU77660A1 (xx)
NL (1) NL7707531A (xx)
SE (1) SE7707880L (xx)
SU (1) SU679143A3 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005047268A2 (en) * 2003-11-10 2005-05-26 X-Ceptor Therapeutics, Inc. Substituted pyrimidine compositions and methods of use

Also Published As

Publication number Publication date
IT1114810B (it) 1986-01-27
SE7707880L (sv) 1978-01-08
CH611283A5 (en) 1979-05-31
SU679143A3 (ru) 1979-08-05
JPS5312877A (en) 1978-02-04
ES460411A2 (es) 1978-10-01
NL7707531A (nl) 1978-01-10
DE2729360A1 (de) 1978-01-12
LU77660A1 (xx) 1978-01-27
GB1548858A (en) 1979-07-18

Similar Documents

Publication Publication Date Title
PH14332A (en) 4-hydroxyphenylalkanolamine derivatives
IL52002A0 (en) M-phenoxybenzamide derivatives
GB1541547A (en) 4-phenoxymethylpiperidine derivatives
GB1521020A (en) 4-hydrox-aporphine derivatives
AU2222977A (en) Tetrahydro-echinocandin b derivatives
GB1543124A (en) 2-iminothiazolidine derivatives
GB1554517A (en) Nogarol derivatives
PT66360A (en) Nicotinoylaminotriazine derivatives
GB1553759A (en) Tetrahyddropyridine derivatives
JPS52105138A (en) Novellphenyll22aminoethanol derivatives
GB1523198A (en) Thiazolo-rifamycin derivatives
GB1549755A (en) N-4-halobutyryl derivatives
GB1524481A (en) Tetrahydo - imidazopyridine derivatives
ZA773485B (en) Hydrazinopyridazine derivatives
GB1545021A (en) 5-norbicyclomycin derivatives
JPS52100431A (en) Anilinoacetate derivatives
JPS532487A (en) Quinoxalinee1*44dioxide derivatives
AU2536577A (en) 2-nitroindandione derivatives
AU2680877A (en) Arylaminopyrimidine derivatives
JPS5297915A (en) Alkylaminoglucopyranoside derivatives
PH13411A (en) 8-adnantylaninometryl ergolene derivatives
JPS5283696A (en) Cephalospoline derivatives
GB1535080A (en) Naphthacenequinone derivatives
JPS52105159A (en) Estrogene derivatives
GB1544289A (en) Thiazolinotriazine derivatives